GOSS
Price
$0.97
Change
+$0.08 (+8.99%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
188M
19 days until earnings call
VNDA
Price
$4.30
Change
-$0.03 (-0.69%)
Updated
Apr 24, 04:59 PM (EDT)
Capitalization
257.17M
6 days until earnings call
Ad is loading...

GOSS vs VNDA

Header iconGOSS vs VNDA Comparison
Open Charts GOSS vs VNDABanner chart's image
Gossamer Bio
Price$0.97
Change+$0.08 (+8.99%)
Volume$10.02K
Capitalization188M
Vanda Pharmaceuticals
Price$4.30
Change-$0.03 (-0.69%)
Volume$25.71K
Capitalization257.17M
GOSS vs VNDA Comparison Chart
Loading...
GOSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
GOSS vs. VNDA commentary
Apr 25, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GOSS is a StrongBuy and VNDA is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 25, 2025
Stock price -- (GOSS: $0.89 vs. VNDA: $4.33)
Brand notoriety: GOSS and VNDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: GOSS: 144% vs. VNDA: 73%
Market capitalization -- GOSS: $188M vs. VNDA: $257.17M
GOSS [@Biotechnology] is valued at $188M. VNDA’s [@Biotechnology] market capitalization is $257.17M. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

GOSS’s FA Score shows that 0 FA rating(s) are green whileVNDA’s FA Score has 1 green FA rating(s).

  • GOSS’s FA Score: 0 green, 5 red.
  • VNDA’s FA Score: 1 green, 4 red.
According to our system of comparison, VNDA is a better buy in the long-term than GOSS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

GOSS’s TA Score shows that 6 TA indicator(s) are bullish while VNDA’s TA Score has 5 bullish TA indicator(s).

  • GOSS’s TA Score: 6 bullish, 4 bearish.
  • VNDA’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, GOSS is a better buy in the short-term than VNDA.

Price Growth

GOSS (@Biotechnology) experienced а +7.16% price change this week, while VNDA (@Biotechnology) price change was -0.92% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +7.94%. For the same industry, the average monthly price growth was -5.37%, and the average quarterly price growth was -12.15%.

Reported Earning Dates

GOSS is expected to report earnings on Aug 12, 2025.

VNDA is expected to report earnings on Jul 24, 2025.

Industries' Descriptions

@Biotechnology (+7.94% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VNDA($257M) has a higher market cap than GOSS($188M). GOSS YTD gains are higher at: -1.669 vs. VNDA (-9.603). VNDA has higher annual earnings (EBITDA): -32.53M vs. GOSS (-39.97M). VNDA has more cash in the bank: 375M vs. GOSS (295M). VNDA has less debt than GOSS: VNDA (12.4M) vs GOSS (203M). VNDA has higher revenues than GOSS: VNDA (199M) vs GOSS (115M).
GOSSVNDAGOSS / VNDA
Capitalization188M257M73%
EBITDA-39.97M-32.53M123%
Gain YTD-1.669-9.60317%
P/E RatioN/A126.00-
Revenue115M199M58%
Total Cash295M375M79%
Total Debt203M12.4M1,637%
FUNDAMENTALS RATINGS
GOSS vs VNDA: Fundamental Ratings
GOSS
VNDA
OUTLOOK RATING
1..100
87
VALUATION
overvalued / fair valued / undervalued
1..100
61
Fair valued
84
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9691
PRICE GROWTH RATING
1..100
6457
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

GOSS's Valuation (61) in the Pharmaceuticals Major industry is in the same range as VNDA (84) in the Biotechnology industry. This means that GOSS’s stock grew similarly to VNDA’s over the last 12 months.

GOSS's Profit vs Risk Rating (100) in the Pharmaceuticals Major industry is in the same range as VNDA (100) in the Biotechnology industry. This means that GOSS’s stock grew similarly to VNDA’s over the last 12 months.

VNDA's SMR Rating (91) in the Biotechnology industry is in the same range as GOSS (96) in the Pharmaceuticals Major industry. This means that VNDA’s stock grew similarly to GOSS’s over the last 12 months.

VNDA's Price Growth Rating (57) in the Biotechnology industry is in the same range as GOSS (64) in the Pharmaceuticals Major industry. This means that VNDA’s stock grew similarly to GOSS’s over the last 12 months.

VNDA's P/E Growth Rating (2) in the Biotechnology industry is significantly better than the same rating for GOSS (100) in the Pharmaceuticals Major industry. This means that VNDA’s stock grew significantly faster than GOSS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
GOSSVNDA
RSI
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 2 days ago
76%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
77%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
79%
Bullish Trend 2 days ago
73%
MACD
ODDS (%)
Bullish Trend 2 days ago
78%
Bullish Trend 2 days ago
72%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
83%
Bearish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
75%
Advances
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 10 days ago
70%
Declines
ODDS (%)
Bearish Trend 21 days ago
88%
Bearish Trend 4 days ago
70%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bullish Trend 2 days ago
76%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
76%
View a ticker or compare two or three
Ad is loading...
GOSS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VNDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GLDAX30.34N/A
N/A
Gabelli Gold A
TILGX24.06N/A
N/A
Nuveen Large Cap Growth R6
WSMDX23.16N/A
N/A
William Blair Small-Mid Cap Growth I
PMVEX22.22N/A
N/A
PGIM Quant Solutions Mid-Cap Val R2
PQJCX12.11N/A
N/A
PGIM Jennison Small-Cap Core Equity R6

GOSS and

Correlation & Price change

A.I.dvisor indicates that over the last year, GOSS has been loosely correlated with MEIP. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if GOSS jumps, then MEIP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GOSS
1D Price
Change %
GOSS100%
+7.51%
MEIP - GOSS
46%
Loosely correlated
N/A
CGEM - GOSS
45%
Loosely correlated
+0.12%
APVO - GOSS
41%
Loosely correlated
+4.05%
VIR - GOSS
41%
Loosely correlated
+2.76%
WHWK - GOSS
41%
Loosely correlated
+0.65%
More

VNDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VNDA has been loosely correlated with AMLX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if VNDA jumps, then AMLX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VNDA
1D Price
Change %
VNDA100%
-1.81%
AMLX - VNDA
42%
Loosely correlated
+2.85%
NAYA - VNDA
40%
Loosely correlated
+6.67%
CLDX - VNDA
37%
Loosely correlated
+0.23%
GOSS - VNDA
37%
Loosely correlated
+7.51%
IKNA - VNDA
37%
Loosely correlated
+1.68%
More